Pharma Industry News

A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.

thehill.com - Nathaniel Weixel - Eric Cantor named new president of pharma trade group
Eric Cantor named new president of pharma trade group
The Hill –

PhRMA, the leading lobbying and trade organization for the U.S. pharmaceutical industry, announced Tuesday that former Republican House Majority Leader Eric Cantor will be taking over as its president. It has been over 10 years since the former…

stltoday.com - Letter: Federal ban on imported prescription drugs serves only Big Pharma
Letter: Federal ban on imported prescription drugs serves only Big Pharma
STLtoday.com –

You have permission to edit this article. Get up-to-the-minute news sent straight to your device.

newswire.ca - Piramal Pharma Solutions and NP2 to Complete Cyclophosphamide Development Phase Next Month
Piramal Pharma Solutions and NP2 to Complete Cyclophosphamide Development Phase Next Month
CNW –

Piramal and NP2 are set to complete the drug development phase of the generic cancer drug cyclophosphamide this October. The development and manufacturing activities are being conducted at Piramal's dedicated sterile injectable facility in…

globenewswire.com - Zealand Pharma - Zealand Pharma to present additional data from Phase 2 ZUPREME-1 trial for petrelintide at EASD 2026 and announces publication of trial results in The Lancet Diabetes & Endocrinology
Zealand Pharma to present additional data from Phase 2 ZUPREME-1 trial for petrelintide at EASD 2026 and announces publication of trial results in The Lancet Diabetes & Endocrinology
GlobeNewswire –

Press release – No. 18 / 2026 Zealand Pharma to present additional data from Phase 2 ZUPREME-1 trial for petrelintide at EASD 2026 and announces publication of trial results in The Lancet Diabetes & Endocrinology Treatment with petrelintide…

prnewswire.com - Piramal Pharma Solutions - Ontario Contributes $1.7 Million Investment to Advance Life Sciences Innovation at Piramal Pharma's Aurora Facility
Ontario Contributes $1.7 Million Investment to Advance Life Sciences Innovation at Piramal Pharma's Aurora Facility
Cision PR Newswire –

With support from the government of Ontario, Piramal Pharma is investing $5,314,000 to upgrade site infrastructure at their Aurora facility, strengthening Ontario's pharmaceutical manufacturing and bolstering domestic production of APIs. This…

thehindubusinessline.com - GST appellate authority upholds ₹4.6 crore ITC claim order against Aurobindo Pharma
GST appellate authority upholds ₹4.6 crore ITC claim order against Aurobindo Pharma
BusinessLine –

Aurobindo Pharma on Tuesday said the Telangana GST appellate authority has upheld a demand for reversal of excess input tax credit claim totalling ₹4.60 crore. The order was passed by the Appellate Joint Commissioner (ST), Malkajgiri…

marketbeat.com - Spyglass Pharma (NASDAQ:SGP) Shares Down 4.5% - What's Next?
Spyglass Pharma (NASDAQ:SGP) Shares Down 4.5% - What's Next?
MarketBeat –

Spyglass Pharma, Inc. (NASDAQ:SGP - Get Free Report)'s share price fell 4.5% during trading on Tuesday. The company traded as low as $24.93 and last traded at $24.8110. 19,056 shares were traded during mid-day trading, a decline of 83% from the…

seekingalpha.com - Detroit Bear - Aquestive Therapeutics: The Market Is Already Pricing In Anaphylam's Success (NASDAQ:AQST)
Aquestive Therapeutics: The Market Is Already Pricing In Anaphylam's Success (NASDAQ:AQST)
Seeking Alpha –

Aquestive Therapeutics offers a differentiated epinephrine product, Anaphylm, but faces pricing and market share headwinds. My base case values AQST at $8, reflecting ~70% upside, but I would only buy closer to $3.50 for an adequate margin of…

globenewswire.com - ALK Abello - ALK expands strategic tablet supply partnership with Catalent
ALK expands strategic tablet supply partnership with Catalent
GlobeNewswire –

Agreement provides long-term expanded access to Catalent's fast-dissolving (Zydis) tablet formulation technology. Supply robustness secured with prioritised manufacturing capacity increase of ~40% to 1.1 billion tablets annually from early 2030s.

newswire.ca - VALITIC™ Expands Retail Industry Visibility Through Shoptalk Fall 2026 in Nashville, USA
VALITIC™ Expands Retail Industry Visibility Through Shoptalk Fall 2026 in Nashville, USA
CNW –

HERZLIYA, Israel and CALGARY, Alberta, Sept. 29, 2026 /CNW/ -- Innocan Pharma Corporation (CSE: INNO) (OTCQB: INNPF) ('Innocan' or the 'Company'), through B.I. Sky Global Ltd., its consumer wellness subsidiary, is pleased to announce that…

rediff.com - Nandita Malik - Indian Stock Markets Decline: Nifty Down 96 Points, Sensex Slips to 72,480 Amid Global Concerns
Indian Stock Markets Decline: Nifty Down 96 Points, Sensex Slips to 72,480 Amid Global Concerns
Rediff.com –

Indian stock markets, including the Sensex and Nifty, experienced their third consecutive day of declines, influenced by rising crude oil prices, high global bond yields, and substantial foreign fund outflows, prompting investor caution. Indian…

statnews.com - Elaine Chen - Eli Lilly's Zepbound combined with amylin drug led to significant weight loss in mid-stage trial
Eli Lilly's Zepbound combined with amylin drug led to significant weight loss in mid-stage trial
STAT –

An investigational combination therapy from Eli Lilly led to significant weight loss in a mid-stage study, but high rates of people stopping the treatment may raise questions about its tolerability. Lilly, which is racing to bring next-generation…

rediff.com - Nandita Malik - Sensex, Nifty Rebound: Easing Crude Prices & IT Stocks Drive Market Recovery
Sensex, Nifty Rebound: Easing Crude Prices & IT Stocks Drive Market Recovery
Rediff.com –

Indian benchmark indices Sensex and Nifty saw a positive rebound in early trade, driven by a moderation in crude oil prices and robust buying in key IT sector stocks, offering relief after two consecutive days of losses. The Sensex advanced 190…

seekingalpha.com - Justin Miller - Novo Nordisk: The Street Sold It For The Wrong Reason (NYSE:NVO)
Novo Nordisk: The Street Sold It For The Wrong Reason (NYSE:NVO)
Seeking Alpha –

Novo Nordisk trades at a discount to sector earnings multiples but appears expensive on free cash flow due to elevated capex. Management's guidance to normalize capex by 2030 is pivotal; free cash flow could rise from DKK 50B to DKK 125B, unlocking…

globenewswire.com - Orion Oyj - Orion Corporation completed share acquisitions
Orion Corporation completed share acquisitions
GlobeNewswire –

STOCK EXCHANGE RELEASE – OTHER INFORMATION DISCLOSED ACCORDING TO THE RULES OF THE EXCHANGE Orion Corporation completed share acquisitions The share acquisitions announced by Orion Corporation on 27 August 2026 have been completed. The…

Receive a Daily briefing on Pharma Industry News

Get Started